Press releases List - Portfolio
3.10.2011
Stallergenes leadership transition
STALLERGENES LEADERSHIP TRANSITION Antony (France), 3 October 2011 - At its meeting held on 3 October 2011, the Board of Directors established new governance for Stallergenes: Albert Saporta will at his own request become Non-Executive Chairman of the Board of Directors of Stallergenes as of 1 January 2012. (...)
Learn more +18.05.2011
Stallergenes obtains a marketing authorization for ORALAIR® in Australia
Antony (France), 18 May 2011 - Stallergenes S.A. has announced that the Australian health authority, the Therapeutic Goods Administration (TGA), has approved the grass pollen sublingual immunotherapy tablet Oralair® in adult and pediatric indications. (...)
Learn more +13.01.2011
Stallergenes: Sales growth and financial position
Antony, France; 13 January 2011 – 6pm. Sales growth and financial position Growth during the fourth quarter was 12%, in line with previous quarters. (...)
Learn more +4.01.2011
Euromedic to divest its dialysis business to Fresenius Medical Care in order to focus on Diagnostics and Cancer Treatment
Amsterdam, Netherlands – Euromedic International, the Pan-European leader in medical services, today announces that it has signed a definitive agreement to divest International Dialysis Centres (“IDC”), its dialysis care business, to Fresenius Medical Care AG & Co, the world’s largest provider of dialysis products and services. (...)
Learn more +26.11.2009
Esaote wins “China Awards” 2009 assigned by “Fondazione Italia-Cina”
Esaote, world leading company in the production of medical technologies, has been presented the prize “China Awards 2009” for the category “Creatori di Valore” at a gala dinner in Milan. (...)
Learn more +18.05.2009
Broncus introduces bronchoscopic tools for lung diseases
LungPoint™ Virtual Bronchoscopic Navigation and Treatment Planning System, Yield™ Mini Doppler Probe and Transbronchial Coring Needles to enhance bronchoscopy. (...)
Learn more +4.12.2008
Broncus Technologies secures $38 million in funding round
Broncus Technologies, Inc., a medical device company developing products for lung diseases announced a $38 million round of Series G funding led by Ares Life Sciences. (...)
Learn more +
Av. Giuseppe-Motta 31-33
CH-1211 Geneva
T +41 58 944 04 00
Email info@areslifesciences.com